Drug class in one race
JAK drugs for Rheumatoid Arthritis
4 tracked JAK drugs in the Rheumatoid Arthritis race. The class explanation lives on the JAK page; the full indication pipeline across every mechanism is on the Rheumatoid Arthritis page.
3 approved / phase 41 Phase 3
Head-to-head evidence: baricitinib vs filgotinib · baricitinib vs tofacitinib · baricitinib vs upadacitinib · filgotinib vs tofacitinib · filgotinib vs upadacitinib · tofacitinib vs upadacitinib